NYSE · CVS
Healthcare · Medical - Healthcare Plans
$93.06
Up+$0.14 (+0.15%)
Updated Aug 31, 2026, 6:41 AM
SID Score
6.3/10
Composite research score
Smart Money
62/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CVS closed at $93.06 after 20 trading sessions, down 11.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $93.40 | $93.93 | $93.01 | $93.06 | 3.99M |
| Aug 27, 2026 | $93.60 | $94.15 | $92.85 | $92.92 | 4.33M |
| Aug 26, 2026 | $93.15 | $94.855 | $92.91 | $94.32 | 6.16M |
| Aug 25, 2026 | $94.11 | $94.11 | $92.71 | $92.90 | 4.1M |
| Aug 24, 2026 | $93.15 | $94.19 | $92.54 | $94.11 | 9.23M |
| Aug 21, 2026 | $94.00 | $94.39 | $92.35 | $93.02 | 5.59M |
| Aug 20, 2026 | $93.23 | $94.26 | $93.21 | $93.65 | 6.44M |
| Aug 19, 2026 | $95.41 | $95.91 | $93.26 | $93.65 | 6.35M |
| Aug 18, 2026 | $94.37 | $95.25 | $93.89 | $94.91 | 6.86M |
| Aug 17, 2026 | $96.29 | $96.50 | $93.74 | $94.01 | 7.3M |
| Aug 14, 2026 | $94.60 | $97.51 | $94.41 | $97.16 | 9.44M |
| Aug 13, 2026 | $95.44 | $96.12 | $94.485 | $94.99 | 6.49M |
| Aug 12, 2026 | $93.75 | $95.15 | $93.15 | $94.72 | 8.26M |
| Aug 11, 2026 | $95.47 | $96.36 | $93.01 | $93.50 | 8.12M |
| Aug 10, 2026 | $95.33 | $96.34 | $94.68 | $95.67 | 7.03M |
| Aug 7, 2026 | $95.20 | $96.28 | $94.57 | $95.70 | 12.4M |
| Aug 6, 2026 | $100.98 | $101.00 | $96.10 | $96.22 | 10.58M |
| Aug 5, 2026 | $93.72 | $100.55 | $93.50 | $99.12 | 18.51M |
| Aug 4, 2026 | $105.00 | $105.00 | $103.27 | $104.42 | 7.23M |
| Aug 3, 2026 | $105.36 | $105.69 | $104.25 | $105.37 | 5.38M |
The latest Smart Investors Daily articles mentioning CVS.
CVS research
Company profile and research snapshot.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | Argus Research | Buy | — |
| Aug 12, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
No generated briefing is available yet.
SeekingAlpha · Aug 24, 2026
CVS Health's vertically integrated healthcare approach underscores their ability to weather the industry headwinds. Read why CVS stock is a Buy.
Yahoo · Aug 22, 2026
One of the pharmacy operator's segments is doing particularly well.
Yahoo · Aug 21, 2026
NORTHAMPTON, MA / ACCESS Newswire / August 21, 2026 /Originally published on CVS Health Company Key points Heart disease disproportionately affects different communities for a variety of factors. Access to care must be paired with education, engagement ...
Yahoo · Aug 20, 2026
NORTHAMPTON, MA / ACCESS Newswire / August 20, 2026 /Originally published on CVS Health Company Newsroom Just weeks after a devastating fire destroyed the CVS Pharmacy® store on East Main Street in Pawling, New York, access to pharmacy care has returned ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CVS.
